NM_024665.7:c.1337A>G

Variant summary

Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong

The NM_024665.7(TBL1XR1):​c.1337A>G​(p.Tyr446Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y446N) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

TBL1XR1
NM_024665.7 missense

Scores

10
4
4

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 7.67

Publications

39 publications found
Variant links:
Genes affected
TBL1XR1 (HGNC:29529): (TBL1X/Y related 1) This gene is a member of the WD40 repeat-containing gene family and shares sequence similarity with transducin (beta)-like 1X-linked (TBL1X). The protein encoded by this gene is thought to be a component of both nuclear receptor corepressor (N-CoR) and histone deacetylase 3 (HDAC 3) complexes, and is required for transcriptional activation by a variety of transcription factors. Mutations in these gene have been associated with some autism spectrum disorders, and one finding suggests that haploinsufficiency of this gene may be a cause of intellectual disability with dysmorphism. Mutations in this gene as well as recurrent translocations involving this gene have also been observed in some tumors. [provided by RefSeq, Mar 2016]
TBL1XR1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability, autosomal dominant 41
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • Pierpont syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 17 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_024665.7
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr3-177033051-A-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 1176162.Status of the report is criteria_provided_single_submitter, 1 stars.
PP2
Missense variant in the TBL1XR1 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 50 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 4.2042 (above the threshold of 3.09). Trascript score misZ: 5.2877 (above the threshold of 3.09). GenCC associations: The gene is linked to complex neurodevelopmental disorder, intellectual disability, autosomal dominant 41, Pierpont syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.892
PP5
Variant 3-177033050-T-C is Pathogenic according to our data. Variant chr3-177033050-T-C is described in ClinVar as Pathogenic. ClinVar VariationId is 225874.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024665.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBL1XR1
NM_024665.7
MANE Select
c.1337A>Gp.Tyr446Cys
missense
Exon 14 of 16NP_078941.2
TBL1XR1
NM_001321193.3
c.1337A>Gp.Tyr446Cys
missense
Exon 14 of 16NP_001308122.1Q9BZK7
TBL1XR1
NM_001321194.3
c.1337A>Gp.Tyr446Cys
missense
Exon 15 of 17NP_001308123.1Q9BZK7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBL1XR1
ENST00000457928.7
TSL:1 MANE Select
c.1337A>Gp.Tyr446Cys
missense
Exon 14 of 16ENSP00000413251.3Q9BZK7
TBL1XR1
ENST00000430069.5
TSL:1
c.1337A>Gp.Tyr446Cys
missense
Exon 14 of 16ENSP00000405574.1Q9BZK7
TBL1XR1
ENST00000352800.10
TSL:5
c.1337A>Gp.Tyr446Cys
missense
Exon 13 of 15ENSP00000263964.11Q9BZK7

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
Pierpont syndrome (3)
1
-
-
Malignant lymphoma, large B-cell, diffuse (1)
1
-
-
not provided (1)
1
-
-
TBL1XR1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.19
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Benign
0.36
T
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Benign
0.059
D
MetaRNN
Pathogenic
0.89
D
MetaSVM
Benign
-0.33
T
MutationAssessor
Benign
1.2
L
PhyloP100
7.7
PrimateAI
Pathogenic
0.91
D
PROVEAN
Pathogenic
-7.6
D
REVEL
Uncertain
0.58
Sift
Uncertain
0.015
D
Sift4G
Uncertain
0.023
D
Polyphen
0.94
P
Vest4
0.89
MutPred
0.52
Loss of phosphorylation at Y446 (P = 0.0358)
MVP
0.85
MPC
2.5
ClinPred
0.99
D
GERP RS
5.5
Varity_R
0.76
gMVP
0.72
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs878854402; hg19: chr3-176750838; COSMIC: COSV70500760; COSMIC: COSV70500760; API